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Abstract 
Background: High oncogenic-risk genotypes of human Papillomavirus (HPV) infect a wide range of human 
cells, including prostate tissue that give rise to benign prostatic hyperplasia and prostatic adenocarcinomas. This 
study aimed to detect DNA of HPV genotype-31 using in situ hybridization technique in prostatic tissues from 
benign prostatic hyperplasia and prostatic adenocarcinomas, and elucidate the association between these HPV 
genotypes and prostatic carcinogenesis. Fifty (50) formalin-fixed, paraffin embedded  prostatic tissue blocks 
were obtained ,among them (25)  tissue biopsies  from  prostatic carcinoma  with different grades and (15) 
benign prostate hyperplastic tissue blocks  as well as (10) apparently normal prostate tissue  autopsies which  
were collected from the archives of Forensic Medicine Institute / Baghdad and used as  prostate healthy control 
groups. Detection and genotyping of HPV was done  by highly sensitive in situ hybridization technique. The 
signals of in situ hybridization reactions of  HPV-31 in prostate cancer cases in the present study was 52% (13 / 
25) whereas in BPH, HPV-31 was detected in 33.3 %( 5 /15).  Non HPV-31 was detected in the apparently 
healthy control group .The highest percentage (24%) of positive- HPV31- DNA ISH reactions was found in 
tissues of prostatic carcinoma showing moderate differentiation .Our results indicate that the oncogenic HPV-31 
might contribute to the development of subset of prostate tumors. 
Keywords: HPV-31; prostate cancer, benign prostatic hyperplasia,in situ hybridization. 
 
1-Introduction:  
Most common neoplasms of the male genital tract involve the prostate gland .( Mc Nicol  and Dodd, 
1990).Prostate cancer is the   fifth common cancer in the world and the second in cancer mortality exceeded only 
by lung cancer (. Bray  etal,2000)  
Viral factors are the most important class of infectious agents associated with human cancers (Mao  etal. 
2003).  
It was estimated that 17-20% of all worldwide incidence of cancers are  attributable to a viral 
etiology(Clifford  etal,2003). 
Human papilloma virus is sexually transmitted in adults. Human papilloma viruses (HPVs) are 
regarded as specific epitheliotropic DNA viruses (Ferenczy and Jenson  1996). 
HPVs can persistently infect prostate epithelium in non immunocomprised host (Scott  etal, 2001).  
To date, more than 200 types of HPVs have been reported, which are classified into low –oncogenic 
risk and high- oncogenic risk types according to their associations with malignant tumors  
(Munoz  etal,2003).  
High oncogenic risk HPV types may integrate into the host cell chromosome, here they interrupt the 
integration of E2 gene that regulatesthe transcription& expression of HPV-E6 & E7 oncoproteins. The  E6 and 
E7 genes reprsent transforming genes and their products are responsible for the alteration of growth patterns of 
the infected cells as well as acting, at least in part, by interfering with host cell control of transcription and the 
cell cycle .( Rubin’s ,2008).  
These oncoproteins  inactivate the cellular tumor suppressor gene products  of p53  and Rb, 
respectively(Satoshi ,2008)(Ghittoni ,etal 2010).  
It is clear that continued expression of these viral oncogenes is necessary for histopathologic 
progression and the malignant phenotype of an HPV-associated tumors(Carole  and Gillison 2006). Recent 
studies suggest that HPV infection may play a role in the development of oral cancers  (Serth  etal,1999). Head 
and neck cancers (Ibrahim ,etal 1992). esophageal cancers           ( Rotola  ,et.al 1992)  Lung cancers(Tu  
etal,1994). and colorectal cancers  (Al-Ahdal  et.al,1996). 
In addition, other reports document the presence of HPV DNA in prostatic tissues(  Al .Jewari et.al, 
2007). 
The involvement of oncogenic (HPVs) in the pathogenesis of prostate cancers is a subject of great 
controversy . (Serth  etal,1999). However, molecular detection of HPV DNA was documented in 2.4%( through 
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53% and) up to 100% in prostate cancer and in 32 %- 93% of benign prostatic hyperplasia(Serth  et.al.,1999). 
So this study aims to assess the in situ hybridization expression of HPV-31 in BPH &prostate cancer 
and to elucidate the correlation of these  high–risk oncogenic HPV-genotype  with development of BPH & 
prostatic carcinogenesis. 
 
2-Materials and methods 
2-1.Patients and tissue samples:Fifty (50) formalin-fixed, paraffin embedded tissues were collected  from 
prostate biopsies that were related to  (25) prostatic carcinoma,(15) benign prostate hyperplasia and (10) 
apperarently  normal prostate .They were collected from records of pathological archives of Teaching 
Laboratories of Medical City Hospital and Forensic Medicine Institute / Baghdad during the period of 
November 2009 to April 2010. The age of these individuals  ranged between 55-95 years. 
The diagnosis of these tissue blocks were based on their accompanied records. A consultant pathologist 
reexamined all these cases to confirm the diagnosis following trimming process of these tissue blocks. 
 
2-2.Methods 
 Detection of HPV by ISH kit (Maxim biotech Inc, USA) was performed on 4µm paraffin embedded tissue 
sections using a biotinylated long DNA probe for HPV-31(cat. No. IH-60058 and IH-60059, respectively).One 
section was mounted on ordinary glass slide and stained with haematoxylin and eosin, whereas other section was 
mounted on charged slide  to be used for in situ hybridization for detecting HPV-31. 
In situ hybridization procedure: - The slides were placed in 60˚C hot- air oven over night. The tissue 
sections were deparaffinized and treated by graded alcohols according to the standard methods. The slides were 
treated then with proteinase K solution.  
One drop of the biotinylated long cDNA probe for HPV-16 and HPV-18was placed on each specified 
slides. Hybridization solutions was placed on the tissue section and placed in the oven at 95˚C for 8-10 minutes 
to denature the double stranded DNA. The slides were then placed in a humid chamber and incubated over night 
at 37˚C to allow hybridization of the probe to the target nucleic acid. The slides were soaked in protein block at 
37˚C until the cover slips fell and then treated with conjugate one to 2 drops of   conjugate  (BCI P/NTB). 
Positive control reactions were performed by replacing the probe with biotinylatedhouse keeping gene probe. 
Negative control was obtained by omitting the probe from hybridization buffer. Then substrate was placed on 
tissue section at room temperature for 30 minutes or until color development was complete. Slides were then 
counterstained using nuclear fast red and sections were mounted with permanent mounting medium (DPX). 
Color development was monitored by viewing the slides under the microscope. A blue colored precipitate 
formed at the site of the probe in positive cells. 
The in situ hybridization signal was evaluated under light microscope at oil emersion (X1000)for 
counting of positive cells . Positive cellswere counted in ten different fields foreach samples and the average of 
positive cells of the ten fields was determined as the scope of our research is to qualify the results as positive or 
negative HPV -31 ISH reactions. A scale zero was given to these results without detectable ISH reaction 
whereas the results pointing for >1% were evaluated as positive ISH reaction  and without the need to include 
the scores 1-3 stated by (27), that are referring to low , intermediate, and high infection.  
 Statistical analysis was done by chi- square test, percentage ,range, mean  and standard deviation .Correlation 
was considered significant when p<0.05.        
 
3-Results 
Table( 1) shows the positive results of HPV DNA-ISH detection ,where 52% ( 13 of total 25) malignant prostate 
tumors showed positive signals. The benign group revealed 33.3% positive signals which  represented 5 out of  
15 cases in this group. None of control group presented positive signals for HPV-ISH test . 
The HPV DNA was detected in a higher percentage in the malignant prostate tumors group than their 
benign counterpart group. Statistically, highly significant differences (p<0.05) were found on comparing the 
results of these study groups. 
 
4-Discussion 
Since human papillomavirus (HPV) infection was first identified as a risk factor for cervical cancer, several 
studies have investigated HPV in relation to prostate cancer with mixed results (Strickler  etal ,1998). When 
Taylor and colleagues (HYPERLINK "HYPERLINK%20%22 
http://europepmc.org/abstract/MED/15988645%222"HYPERLINK"http://europepmc.org/abstract/MED/159886
45"(Rosenblatt etal,2003). combined the results of ten of these studies, they observed a significant positive 
association between HPV and prostate cancer. 
Many studies showed the association between HPV and PCa .These studies showed that HPV 
prevalence varies from 2%to 100% in PCa samples, The most reported types of HPVs in prostate cancers were 
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HPV types 16,18,33 and 31   (Anwar etal,1992)and (Leiros  etal, 2005).  
The present results are much higher than the results of positivity of HPV31 in the examined prostatic cancerous 
tissues reported by( Amitis  etal,2011) and (Leiros  etal, 2005). 
Where they found (4.3%, 12%, 32%), respectively. 
It is possible that the tissues of prostate cancer with negative results by the present in situ hybridization study 
may not have an adequate copy numbers of this virus to permit its detection by ISH while it could show positive 
results on PCR (Al-Ahdal  etal, 1996).    
By analogy, it was found that the present findings of HPV 16 &31 in an equal proportions are 
consistent to those studies done in Iraq by Mohammed Ali ( Mohammed-Ali,2001) and (Al-
Azzawi,2006)and(Bakir ,2006) and (Khashman ,2008(AL-Mahbobi ,2011) and( Al-Aizzi,  2011)and(Al-Alwany,  
2013).  who found that the HPV 16,18 ,31& 33as the prevalent types in their studied group of the 
cervical ,laryngeal ,esophageal ,oral, prostatic ,ovarian carcinomas and breast carcinoma ,respectively.       
In addition, the lower numbers of the included prostatic tissues in  the present (as well as other studies) 
which were subjected for molecular testing as well as there was a shortage of knowledge regarding the 
prevalences of each HPV genotype in the general population of each communities and /or countries precluded 
any clear and definitive explanation regarding such differences and discrepancies in the reported results of  
positive percentages of HPV ( this was noted even  for those results that were reported  by the same researcher  
and in the same  patients of  that specific country but at different, even short, time interval of achieving these 
studies) .(Mc Nicol  and Dodd ,1990).  
Although human papillomavirus type16 and type 18 are known to play a role in the development of 
neoplastic disorders of the urogenital organs, the presence of HPV-16 and   
HPV-18 in prostatic tissues with benign hyperplasia has been a matter of controversy(Al .Jewari ,2007). 
The present study was extended to include a set ofbenign prostatic hyperplasia tissues to be tested by ISH 
technique for these  important highly oncogenic HPV genotypes.  
By analogy ,the results of this study were in disagreement with the findings of   (Ibrahim  etal,1992). 
who found 50% of HPV16 in BPH by using PCR method and  also consistent  with the findings of each  
(Ibrahim  etal,1992).who found 20% of HPV18 in BPH) and (Al .Jewari ,2007)  who found 30.8% of HPV-18 in 
BPH) by using PCR &Southern blot hybridization  techniques. 
However ,our  results are lower than those reported by (1) who found HPV16 and HPV18 in BPH in a 
percentage rate of  (93.3% &20%) respectively; those reported by  (McNicol & Dodd ,1991). ( 60.7%)in BPH by 
using PCR method; and  those  reported by (  (Rotola  etal ,1992)  who found (82%) positivty of HPV-16 in 
BPH cases. On the other hand, some investigators have reported negative findings of HPV in BPH samples. In 
this respect, a pilot study by ( Hisada  etal,2000).included a total of 10 BPH samples that were proved to be 
negative at for HPV by both PCR and in situ hybridization. Also, our obtained results are higher than (McNicol 
& Dodd ,1991). who found HPV18 (5.4%); (Al .Jewari ,2007). who found (15.4%) for co –infection 
HPV16&HPV18 in their examined benign hyperplastic tissues.  
The differences in the present obtained percentages are a reflection of low prevalence of HPV in our 
Iraqi patients and as reported by( Al Jewari 2007).that may constitutes a probable cause for the differences 
between all Iraqi studies and world-wide studies. (Robbins and Cotran, 2010).Therefore, other factors and agents 
might multifactorially or co-factoriallyplayed a role in initiation and promotion in prostate carcinogenesis of our 
country.  
Although many researches tried to present evidences for liability of conversion of subset of BPH into 
PC, yet scientists have not confirmed the change of BPH to PC ( Wilcox  etal, 1998).  Prostate cancer like that of 
cervical cancer is also preceded by precursor lesions called prostatic intraepithelial neoplasia (PIN) which are 
equally paralleled to CIN in cervical cancer  ( Strickler  etal,1998).. In view of these facts &observations, and   
likewise  that of HPV role in cervical carcinogenesis ,the present results could fortify the possibility of changing 
PIN lesions to PC via the role of highly oncogenic risk HPV types in the course of prostatic carcinogenesis. 
The detection of such high risk HPV types in BPH would not be interpreted   as a chance phenomenon 
or left without giving a critical importance for the possibility of HPV in initiation or enhancing the conversion of 
a subset of BPH into the prostatic carcinogenesis to change into PIN and /or PC .  
Small size of the studied samples compromised the statistical power of this study to detect the effects of 
these factors under consideration. In addition, the lack of detailed clinical information attached to those prostate 
tissue samples that were  enrolled in this study has deprived the present study to reach to a solid impression for 
the real role of  those mixed viral infections in prostate carcinogenesis and in turn raised a suggestion to compel 
an integrate team-work study, at molecular and virological levels to elucidate the role of these factors and many 
other agents in prostate carcinogenesis in this country. Also in the future, it will be interesting to design 
experimental studies to understand the synergistic effect of HPV with EBV and /or HSV mixed infections on  
prostate cancer. 
In view of the clear variations in the results of HPV in BPH from the present study and many other 
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studies, more investigations should be carried out before a possible conclusion that the prostate may be a 
potential reservoir for the sexual transmission of high risk HPVs can be made. 
 
Conclusions 
The high percentage of high-oncogenic risk  HPV31-associated PCa might reflect  a crucial role for this 
important sexually –transmitted  disease in the pathogenesis of  PCa and BPH and their probable transforming 
role along the pivot of prostatic carcinogenesis. 
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Table (1) : Frequency distribution of HPV DNA signal scoring among the malignant prostate tumors , 













HPV signal scoring 




100.0 10 66.7 10/15 48 12/25 Negative 
0.00 0 33.3 5/15 52 13/25 Positive 
0 0 80 4/5 46.2 6/13 I 
Scoring 0 0 20 1/5 38.5 5/13 II 
0 0 0.00 0 15.3 2/13 III 
 55.5  67.1  95.6 Mean Rank 
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Distribution of HPV31-associated prostate 
carcinoma according to the grade/differentiation of 
cancer  
(Table 2) shows the correlation of infection with  high-
risk HPV31 genotype and their scoring with  prostate 
cancer grading . Thirteen cases out of 25 showed 
positive for HPV31-ISH reaction .Twelve  percent 
( 12 % :3 cases out of 25) of prostate carcinoma that 
have well differentiated grade . Also , itswere  found 
that 24% (6 cases out of 25) and 16% ( 4 cases out of 25 
cases )  of prostate carcinoma that showed moderately 
differentiated grade and poorly differentiated grade , 
respectively. Statistically, no significant correlations 
between HPV31 infection and the breast cancer grade . 
 
 




Count 3 4 7 
% within grade 12% 16% 28% 
% within HPV31 23.1% 0.00 23.1% 
Moderate 
Count 6 3 9 
% within grade %24 12% 36% 
% within HPV31 46.1% 0.00 46.1% 
Poor 
Count 4 5 9 
% within grade 16% %20 36% 
% within HPV31 30.8% 0.00 30.2% 
Total 
Count 13 12 25 
% within grade 52% 48% 100.0% 
% within HPV31 100.0% 00.0% 100.0% 
 
 (Table 2) shows the correlation of infection with  high-risk HPV31 genotype and their scoring with  prostate 
cancer grading . Thirteen cases out of 25 showed positive for HPV31-ISH reaction .Twelve  percent ( 12 % :3 
cases out of 25) of prostate carcinoma that have well differentiated grade . Also , itswere  found that 24% (6 
cases out of 25) and 16% ( 4 cases out of 25 cases )  of prostate carcinoma that showed moderately differentiated 
grade and poorly differentiated grade , respectively. Statistically, no significant correlations between HPV31 
infection and the breast cancer grade . 
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Figure (1): In situ hybridization results for HPV-31 DNA- detection in prostatic adenocarcinomas; 
BCIP/NBT stained and counter stained by nuclear fast red; A.prostate tissue with negative ISH reaction 
for HPV-31 (40X).  B. prostate cancer with positive ISH reaction for HPV-31 (40X). 
 
<=>?ا ABCDE?ا FG سوJCKL?ا AMNOP?ا يJ=R?ا وذ رKUVWا AXKطJZ?ا  A?K[?ا ع]X   31 A^ _EZXWا ةذ]VaM?ا Fم cdJM?ا FNeKfM?ا. نKطJZ? 
تKijوJR?ا klmi?او تKijوJR?ا nNMP?ا 
_opl?ا  
_NLOV _jارn?ا: تVWوYZV[\ا ^_`_ab\ا ^ZYcd\ا تاذ رVghiا jkVطYm\ا j\Vn\ا o_pq r_ط sWاو tم VZvw\ا ^ZYcd\ا Vxy`z{و ^|mkأ تV~WوYd\ا 
^Zدم \ا ثو ماروأ ة_` تVkVطYWو ^Z Vx_. 
فnھ _jارn?ا: يYb~\ا t سوYZV[\ا j`_ab\ا يYcd\ا وذ `k رVghiا j\Vn\ا 31 ^|mkiV{ ةذh`\ا tم تVkVطYW تV~WوYd\ا تiVو wz~\ا 
_`b\ا j تV~WوYd\ا Y_m[qو V`xqVv ^_a`n{ ثو رg~\ا jkVطYm\ا j تV~WوYd\ا. 
دا]M?ا tuاJطو vM[?ا:  n`ج ^_kV` نm`hو ^y_ tم _mk تV~WوYd\ا ظ[b`\ا t_\Vمر[\V{ ر`g`\او s`c{ t_ارVd\ا Vxyم 28 ^y_ ةذhم 
tم عw\ا ^_|_my\ا^Z_b\ا  tم نVطYW تV~WوYd\ا و 20 ىYhأ tم تiV wz~\ا _`b\ا j تV~WوYd\ا V`y_{ تhأ 10 عh ^_|_mk tم xnم 
og\ا j\n\ا j دا{ _ مw~Wأ ^`|` ةYg_W ./ q `n\ا ^ZYg{ t_|x~\ا jn `\ا تاذ ^_WVmb\ا ^_\Vn\ا rc¡a\ t سوYZV[\ا 
j`_ab\ا يYcd\ا وذ رVghiا j\Vn\ا عk 16و18.  
wuKix?ا: b وأ ^Wار\ا ^_\Vb\ا ¢k{ ^dmk ثو سوYZV[\ا j`_ab\ا يYcd\ا وذ رVghiا j\Vn\ا31 j تiV نVطYW تV~WوYd\ا 
kV52 %13 ) tم £ا 25¢\V).V`y_{ 33.3%(5 tم £ا 15 ¢\V) ^dmk V`xو j تiV wz~\ا jqV~WوYd\ا _`b\ا ¤b[{ t_|x~\ا 
jn `\ا. \ |mq ^\V V[q t_|xq jn م سوY_[a\  j تiV ^|mkiا j ^`|م ةYg_m\ا ^_n_dg\ا.  
تKyKixijWا: سوYZV[\ا j`_ab\ا يYcd\ا وذ رVghiا j\Vn\ا 31   onaZ ارود V`xم j ثو رgqو نVطYW VZvw\ا j تV~WوYd\ا و تiV ا 
wz~\ا _`b\ا تV~WوYda\. 
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